Search results
Bristol Myers (BMY) Gets FDA Nod for Label Expansion of Augtyro
Zacks via Yahoo Finance· 18 hours agoThe FDA approves Bristol Myers' (BMY) cancer drug Augtyro for the treatment of adult and pediatric...
Bristol Myers Squibb's Augtyro Gets FDA Accelerated Approval
Morningstar· 2 days agoBy Denny Jacob Bristol Myers Squibb disclosed that the U.S. Food and Drug Administration granted accelerated approval of Augtyro. The biopharmaceutical product developer said ...
Supreme Court unanimously rejects challenge to FDA approval of abortion drug mifepristone
UPI· 2 days ago1 of 2 | The U.S. Supreme Court Thursday unanimously rejected a challenge to the abortion drug...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 2 days agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
Supreme Court’s abortion pill ruling puts new focus on conservative Trump judge in Texas
CNN via Yahoo News· 3 hours agoNow, both sides in the abortion debate...doctor’s visit and allowing it to be used longer in a...
SCOTUS ruling on mifepristone could have lasting impact on FDA regulation: Experts
ABC 7 Chicago· 1 day agoThe court unanimously struck down a lawsuit seeking to restrict nationwide access to mifepristone,...
Geron (GERN) Wins FDA Approval for Blood Cancer Drug, Stock Up
Zacks via Yahoo Finance· 5 days agoGeron's (GERN) shares rise on approval of its first drug. The FDA approves imetelstat for the...
Leo’s single-dose autoinjector secures FDA approval for atopic dermatitis
Pharmaceutical Technology via Yahoo Finance· 2 days agoLeo Pharma has announced that its injection treatment for atopic dermatitis, Adbry...
Supreme Court Rejects Challenge to FDA Approval of Mifepristone: Impact on Health Plans | JD Supra
JD Supra· 1 day agoOn Thursday, the U.S. Supreme Court rejected a challenge to the U.S. Food and Drug Administration (FDA) approval of the drug mifepristone, which is used ...
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails -...
Benzinga· 18 hours agoPfizer's PFE phase III study of investigational gene therapy, fordadistrogene movaparvovec, for...